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Available online 14 January 2016The KCL027 human embryonic stem cell line was derived from an embryo donated for research that carried an
autosomal dominantmutation affecting one allele of theHTT gene encoding huntingtin (43 trinucleotide repeats;
21 for the normal allele). The ICM was isolated using laser microsurgery and plated on γ-irradiated human
foreskin ﬁbroblasts. Both the derivation and cell line propagation were performed in an animal product-free
environment. Pluripotent state and differentiation potential were conﬁrmed by in vitro and in vivo assays.
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rade Research
isease status (Fig. 1) Mutation affecting one allele of the HTT gene
encoding huntingtin (~43 CAG repeats; 21
for the normal allele) associated with
Huntington's disease (Jacquet et al., 2015)aryotype (aCGH) Deletion in the chromosome 2q37.3
(242,930,599–242,948,040) × 1; known
polymorphic variant.NA ﬁngerprint Allele sizes (in bp) of 17 microsatellite
markers speciﬁc for chromosomes 13, 18 and
21 (Jacquet et al., 2015)LA typing HLA-1: 02,03; -B: 07,35, -C: 04,07; DRB1: 01;
DQB1: 05:01, 05:01/03iability testing Pass
luripotent markers
(immunostaining) (Fig. 2)NANOG, OCT4, TRA-1-60, TRA-1-81, AP activity
(Jacquet et al., 2015)ree germ layer differentiation
in vitro (immunostaining)
(Fig. 3)Endoderm: AFP (α-fetoprotein); Ectoderm:
TUBB3 (tubulin, β3 class III); Mesoderm:
ACTA2 (actin, α2, smooth muscle) (Jacquet
et al., 2015)ree germ layer differentiation
in vivo (teratomas) (Fig. 4)Endoderm: AFP, GATA4. Ectoderm: TUBB3,
GFAP (glial ﬁbrillary acidic protein). Mesoderm:
DES (desmin), Alcian Blue and periodic
acid–Schiff (PAS)-stained cartilage (Jacquet
et al., 2015)rgeted differentiation (Fig. 5) Cardiomyocytes: TNNT2 (cardiac troponin
T) immunostainingbling lines available KCL028SiWe generated KCL027 research grade hESC line following protocols,
established previously (Ilic et al., 2012; Stephenson et al., 2012). The ex-
pression of the pluripotencymarkers was tested after freeze/thaw cycle
(Fig. 2; Jacquet et al., 2015). Differentiation potential into three germ
layers was veriﬁed in vitro (Figs. 3 and 5; Jacquet et al., 2015) and
in vivo (Fig. 4; Jacquet et al., 2015).Materials and methods
Consenting process
We distribute Patient Information Sheet (PIS) and consent form to
the in vitro fertilization (IVF) patients if they opted to donate to research
embryos that were stored for 5 or 10 years. They mail signed consent
back to us and that might be months after the PIS and consent were
mailed to them. If in the meantime new versions of PIS/consent are im-
plemented, we do not send these to the patients or ask them to re-sign;
thewhole process is donewith the version thatwas given them initially.
The PIS/consent documents (PGD-V.8) were created on Jul. 01, 2010.
HFEA Code of Practice that was in effect at the time of document crea-
tion: Edition 8 — R.2 (http://www.hfea.gov.uk/2999.html). The donor
couple signed the consent on Jan. 12, 2011. HFEA Code of Practice that
was in effect at the time of donor signature: Edition 8 — R.2. HFEA
Code of Practice Edition 8 — R.2 was in effect: Apr. 07, 2010–Apr. 06,
2011.undergoing IVF had 12 embryos in this particular cycle
two of them.Embryo culture and micromanipulation
Embryo culture and laser-assisted dissection of inner cell mass
(ICM) were carried out as previously described in details (Ilic et al.,
2012; Stephenson et al., 2012). The cellular area containing the ICM
was then washed and transferred to plates containing mitotically
inactivated human neonatal foreskin ﬁbroblasts (HFF).
Cell culture
ICM plated onmitotically inactivated HFF was cultured as described
(Ilic et al., 2012; Stephenson et al., 2012). TE cells were removed
mechanically from outgrowth (Ilic et al., 2007; Ilic et al., 2010). hESC
colonies were expanded and cryopreserved at the third passage.
Viability test
Straws with the earliest frozen passage (p.2–3) are thawed and new
colonies are counted three days later. These colonies are then expanded
up to passage 8, atwhich point cellswere part frozen and part subjected
to standard battery of tests (pluripotency markers, in vitro and in vivo
differentiation capability, genetics, sterility, mycoplasma).
Pluripotency markers
Pluripotencywas assessed using two different techniques: enzymat-
ic activity assay [alkaline phosphatase (AP) assay] and immunostaining
as described (Ilic et al., 2012; Stephenson et al., 2012).
Differentiation
Spontaneous differentiation into three germ layers was assessed
in vitro and in vivo (Jacquet et al., 2015). Targeted differentiation in
cardiomyocytes followed the protocols described earlier (Jacquet
et al., 2015; Laﬂamme et al., 2007).
Genotyping
DNA was extracted from hESC cultures using a Chemagen DNA
extraction robot according to the manufacturer's instructions. Ampliﬁ-
cation of polymorphic microsatellite markers was carried out as
described (Ilic et al., 2012). Allele sizes were recorded to give a unique
ﬁngerprint of each cell line.
Array comparative genomic hybridization (aCGH)
aCGH was performed as described in details (Ilic et al., 2012).
HLA typing
HLA-A, -B and -DRB1 typing was performed with a PCR sequence-
speciﬁc oligonucleotide probe (SSOP; Luminex, Austin, TX, USA). Three embryos were normal, whereas nine carried themutation inHTT andwere donated
Fig. 2. Expression of pluripotency markers. Pluripotency is conﬁrmed by immunostaining (Oct4, Nanog, TRA-1-60, TRA-1-81) and alkaline phosphatase (AP) activity assay. Scale bar,
20 μm.
276 L. Jacquet et al. / Stem Cell Research 16 (2016) 274–277hybridization protocol at the certiﬁed Clinical Transplantation Laborato-
ry, Guy's and St Thomas' NHS Foundation Trust and Serco Plc. (GSTS) Pa-
thology (Guy's Hospital, London, UK) as described (Jacquet et al., 2013).
Author disclosure statement
There are no competing ﬁnancial interests in this study.Fig. 3. Differentiation of three germ layers in vitro is conﬁrmed by detection of markers: smoot
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Fig. 4. Differentiation of three germ layers in vivo. Teratomas were encapsulated and did not
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Fig. 5. TNNT2 (green) immunostaining on day 30 of cardiac differentiation. Nuclei are
visualized with Hoechst 33342 (blue). Scale bar, 10 μm.
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